Recent reports have positioned The Pharmaceuticals under significant examination concerning its pharmaceutical manufacturing and marketing practices. Claims regarding possibly unconventional research protocols and aggressive marketing approaches have ignited broad unease among officials, stakeholders, and public protection groups. The situation is